Chiba University may withdraw paper concerning clinical studies on Novartis’ Diovan

According to officials at Chiba University, reliability of the study is low, scientific falue is poor, and there may be a problem of conflict of interest.

Nikkei Biotech news release, April 27, 2014

Chiba University may withdraw paper concerning clinical studies on Novartis’ Diovan
Scroll to top